Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker RPRX
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 4, 2026 | RPRX Royalty Pharma plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 5, 2026 | RPRX Royalty Pharma plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 4, 2026 | RPRX Royalty Pharma plc | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 28, 2026 | RPRX Royalty Pharma plc | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| May 28, 2026 | RPRX Royalty Pharma plc | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 6, 2026 | RPRX Royalty Pharma plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 13, 2026 | RPRX Royalty Pharma plc | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 11, 2026 | RPRX Royalty Pharma plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 22, 2025 | RPRX Royalty Pharma plc | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Dec 22, 2025 | RPRX Royalty Pharma plc | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 5, 2025 | RPRX Royalty Pharma plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 16, 2025 | RPRX Royalty Pharma plc | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 16, 2025 | RPRX Royalty Pharma plc | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 13, 2025 | RPRX Royalty Pharma plc | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 6, 2025 | RPRX Royalty Pharma plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 17, 2025 | RPRX Royalty Pharma plc | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 19, 2025 | RPRX Royalty Pharma plc | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| May 19, 2025 | RPRX Royalty Pharma plc | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 19, 2025 | RPRX Royalty Pharma plc | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| May 19, 2025 | RPRX Royalty Pharma plc | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| May 19, 2025 | RPRX Royalty Pharma plc | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 12, 2025 | RPRX Royalty Pharma plc | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 8, 2025 | RPRX Royalty Pharma plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 11, 2025 | RPRX Royalty Pharma plc | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Apr 10, 2025 | RPRX Royalty Pharma plc | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Feb 11, 2025 | RPRX Royalty Pharma plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 13, 2025 | RPRX Royalty Pharma plc | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 10, 2025 | RPRX Royalty Pharma plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 10, 2025 | RPRX Royalty Pharma plc | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 10, 2025 | RPRX Royalty Pharma plc | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jan 10, 2025 | RPRX Royalty Pharma plc | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 31, 2024 | RPRX Royalty Pharma plc | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Dec 31, 2024 | RPRX Royalty Pharma plc | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 6, 2024 | RPRX Royalty Pharma plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
34 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:35 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances